Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference Sep 05, 2023
Mustang Bio Announces First Data from Ongoing Multicenter Phase 1/2 Clinical Trial Evaluating MB-106 CAR-T Cell Therapy Aug 16, 2023
Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights Aug 14, 2023
Mustang Bio Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights Aug 14, 2023
Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights Aug 14, 2023
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights Aug 10, 2023
Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights Aug 08, 2023
Journey Medical Corporation to Announce Second Quarter 2023 Financial Results on August 8, 2023 Aug 02, 2023
